Physician profile
Beth P Gelman
NPI 1295838530
$1,783.13
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $27.87 · 2024: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,640.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,640.00 | 2024 | |
| Neos Therapeutics, LP | $28.60 | 2019 | |
| Sanofi Pasteur INC. | $25.29 | 2019-2020 | |
| Epi Health, LLC | $19.40 | 2019 | |
| Kaleo, INC. | $15.00 | 2019 | |
| Cranial Technologies, INC | $15.00 | 2019 | |
| Glaxosmithkline, LLC. | $14.94 | 2020 | |
| Tris Pharma INC | $13.92 | 2019 | |
| Shire North American Group INC | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Gelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.